JWM
WST icon

JGP Wealth Management’s West Pharmaceutical WST Stock Holding History

JGP Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,280
Closed -$623K – 244
2025
Q3 		$623K Buy
2,280
+277
+14% +$67.3K 0.07% 127
2025
Q2 		$438K Buy
2,003
+492
+33% +$105K 0.05% 141
2025
Q1 		$338K Sell
1,511
-896
-37% -$247K 0.04% 148
2024
Q4 		$788K Buy
2,407
+303
+14% +$95.4K 0.1% 110
2024
Q3 		$632K Buy
2,104
+141
+7% +$43.2K 0.08% 116
2024
Q2 		$647K Buy
1,963
+171
+10% +$60.4K 0.09% 111
2024
Q1 		$709K Buy
+1,792
New +$663K 0.1% 106

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JGP Wealth Management's WST Position: Q4 2025 in Review

JGP Wealth Management sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 2,280 shares — an estimated $623K sold.

JGP Wealth Management first reported a position in WST in Q1 2024 and held it in 7 quarters. The position peaked at $788K in Q4 2024. 803 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • JGP Wealth Management reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • JGP Wealth Management sold 2,280 West Pharmaceutical shares in Q4 2025, an estimated $623K.
  • JGP Wealth Management first reported a position in West Pharmaceutical in Q1 2024 and held it in 7 quarters.
  • JGP Wealth Management's West Pharmaceutical position peaked at $788K in Q4 2024.
  • 803 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on JGP Wealth Management's 13F filing for Q4 2025, filed 12 Jan 2026.